McLean Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
McLean Asset Management's LLY Position: Q3 2026 in Review
McLean Asset Management reduced its Eli Lilly (LLY) stake by 13% in Q3 2026, selling an estimated $223K and leaving 1,231 shares worth $1.68M. The position accounts for 0.22% of the portfolio, ranked #43.
McLean Asset Management first reported a position in LLY in Q1 2021 and has held it in 23 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- McLean Asset Management held 1,231 shares of Eli Lilly worth $1.68M as of Q3 2026.
- McLean Asset Management sold 189 Eli Lilly shares in Q3 2026, an estimated $223K.
- Eli Lilly made up 0.22% of McLean Asset Management's portfolio in Q3 2026, its #43 holding.
- McLean Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 23 quarters since.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on McLean Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.